欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (3): 264-270.doi: 10.12092/j.issn.1009-2501.2021.03.004

• 基础研究 • 上一篇    下一篇

低氧诱导因子-1α对脓毒症肠黏膜屏障的保护作用

何锐1,滕文彬1,姚刘旭2,单跃2,祝胜美1,李玉红3   

  1. 1浙江大学医学院附属第一医院麻醉科,杭州 310000,浙江;2绍兴市人民医院麻醉科,绍兴 312000,浙江;3树人大学树兰国际医学院附属树兰(杭州)医院麻醉科,杭州 310004,浙江

  • 收稿日期:2020-10-14 修回日期:2020-12-29 出版日期:2021-03-26 发布日期:2021-04-06
  • 通讯作者: 李玉红,通信作者,女,博士,教授/主任医师,研究方向:围手术期肠功能保护。 Tel: 0571-5675-7123 E-mail: yuh_li@zju.edu.cn 祝胜美,共同通信作者,博士,主任医师,研究方向:围手术期脏器功能保护。 Tel: 0571-8723-6661 E-mail: smzhu20088@zju.edu.cn
  • 作者简介:何锐,男,本科,副主任医师,研究方向:围手术期肠功能保护。 Tel: 13575546562 E-mail: 15347172@qq.com
  • 基金资助:
    浙江省科学技术厅公益项目(LGF19H030011);浙江省医药卫生科技计划项目(2020KY329,2019306157)

Protective effect of hypoxia inducible factor-1α on intestinal mucosal barrier in sepsis

HE Rui 1, TENG Wenbin 1, YAO Liuxu 2, SHAN Yue 2, ZHU Shengmei 1, LI Yuhong 3   

  1. 1 Department of Anesthesiology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang, China; 2 Department of Anesthesiology, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang, China; 3 Shulan Hangzhou hospital, Shulan International Medical College, Shuren University, Hangzhou 310004, Zhejiang, China
  • Received:2020-10-14 Revised:2020-12-29 Online:2021-03-26 Published:2021-04-06

摘要: 目的:探讨低氧诱导因子-1α(HIF-1α)对脓毒症肠黏膜屏障的影响及机制。方法:SD大鼠随机分4组:假手术组、脓毒症组、脓毒症+HIF-1α刺激剂组(脓毒症+DMOG组)、脓毒症+HIF-1α抑制剂组(脓毒症+Bay87-2243组),每组6只。采用盲肠结扎穿孔(cecal ligation and perforation, CLP)建立脓毒症模型。ELISA检测大鼠血浆炎性标记物IL-1β、IL-6、TNF-α,氧化应激标记物丙二醛(MDA)以及抗氧化因子超氧化物歧化酶(SOD)、过氧化氢酶(CAT)的水平。Western blot检测大鼠肠黏膜HIF-1α表达。HE染色检测肠黏膜病理学损伤。结果:与假手术组相比,脓毒症大鼠炎症因子、氧化应激因子以及HIF-1α显著上调(P<0.05);给予腹腔注射DMOG明显降低脓毒症大鼠血浆IL-1β、IL-6、TNF-α、MDA水平(P<0.05);增加血浆SOD、CAT水平(P<0.05);HIF-1α表达上调(P<0.05),肠黏膜病理损伤减轻,Chiu's评分显著降低(P<0.05)。口服灌胃Bay87-2243则得到相反的结果。 结论:HIF-1α对脓毒症肠黏膜损伤具有保护作用,其机制可能与缓解脓毒症炎性反应和抑制氧化应激水平有关。

关键词: 脓毒症, 炎症反应, 氧化应激反应, 低氧诱导因子1α, 低氧诱导因子1α刺激剂, 低氧诱导因子1α抑制剂

Abstract: AIM: To investigate the effect and mechanism of hypoxia inducible factor-1α on intestinal mucosal barrier in sepsis.  METHODS: SD rats were randomly divided into 4 groups: sham group, sepsis group, sepsis+HIF-1α stimulant (sepsis+DMOG group), sepsis+HIF-1α inhibitor (sepsis+Bay87-2243 group), 6 rats in each group. Sepsis model was established by cecal ligation and perforation (CLP). The levels of inflammatory markers IL-1β, IL-6, TNF-α, oxidative stress markers MDA and antioxidant factors SOD and CAT were detected by ELISA and the expression of HIF-1α in intestinal mucosa was detected by Western blot. The pathological damage of intestinal mucosa was detected by HE staining. RESULTS: Inflammatory factors, oxidative stress factors and HIF-1α were significantly up-regulated in septic rats (P<0.05). The contents of IL-1β, IL-6, TNF-α and MDA in plasma were significantly decreased by intraperitoneal injection of DMOG (P<0.05); the levels of SOD and CAT in plasma were increased (P<0.05), HIF-1α was up-regulated (P<0.05), and the pathological damage of intestinal mucosa was alleviated, with decreased Chiu's score (P<0.05). Oral administration of Bay87-2243 gave the opposite result. CONCLUSION: HIF-1α has a protective effect on intestinal mucosal injury in sepsis. The mechanism may be related to the alleviation of inflammatory response and inhibition of oxidative stress.

Key words: sepsis, inflammatory response, oxidative stress response, hypoxia inducible factor-1α, hypoxia inducible factor-1α stimulant, hypoxia inducible factor-1α inhibitor

中图分类号: